Lanzon, Renielyn .

HRN: 24-54-14  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/03/2024
CEFUROXIME 750MG (VIAL)
02/03/2024
02/09/2024
IV
750mg
Q8H
PCAP
Waiting Final Action 
02/18/2024
MUPIROCIN 2%, 15G (TUBE)
02/18/2024
02/22/2024
APPLY ON SKIN
Thinly
Q8h
IV Site Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: